原创力文档- 1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
- 2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
查看更多
抗高血压药物引起的糖尿病不容忽视(英文）PPT
DRUG INDUCED DIABETES DURING ANTIHYPERTENSIVE THERAPY IS IMPORTANT - BUT ;Prevalence of diabetes among Chinese adults aged 35–64 years in the 1994 Chinese National Survey (10) and 2000–2001 InterASIA Study;Percent of deaths;CV mortality rate per 10,000 person-years;Annual Incidence of Diabetes in Hypertensive Patients;THE ISSUES;Non-CVD Consequences of NOD;CVD Consequences;.;Barzilay, J. I. et al ALLHAT. Arch Intern Med 2006;166:2191-2201.; Effect of ACEIs and ARBs on CVD Mortality;Age-gender–adjusted in treatment CVD and non-CVD by baseline FBG among hypertensive patients.;Myocardial infarction (fatal and nonfatal) in hypertensive patients according to DM status ;Diabetes Incidence - 4 Years (follow-up FBS ? 126 mg/dL for those 126 mg/dL at baseline);Ramipril v. Placebo in high risk patients with IGT at baseline;Ramipril v. Placebo CVD non-CVD Outcomes;.;CV death (%);CONCLUSIONS FROM SHEP +; Reduction in major CVD among 6,000 DM in HPS associated with 38/89 ? LDL/CHOL by Statin;Incidence of MI and Microvascular Endpoints by Mean SBP and HbA1c in UKPDS;UNCERTAINTY CONTINUES ACCORD AND ADVANCE;Major CV Event Rate In HOT;CONCLUSIONS;CLINICAL IMPLICATIONS
文档评论（0）